English
Home > Products > CAS NO 57282-49-2

China CAS NO 57282-49-2 Factory

We believe in: Innovation is our soul and spirit. Excellent is our life. Buyer want is our God for CAS NO 57282-49-2,57282-49-2,L-Lysine API,L-Lysine, High-quality is factory's everyday living , Focus on customers' demand would be the source of organization survival and advancement, We adhere to honesty and good faith doing the job attitude, seeking forward towards your coming !
CAS NO 57282-49-2, We also provide OEM service that caters to your specific needs and requirements. With a strong team of experienced engineers in hose design and development, we value every opportunity to provide best products for our customers.

Related Products

Hot Products

  • Yttrium(III) chloride

    Yttrium(III) chloride

    Product Name:Yttrium(III) chloride
    Molecular Formula:Cl3Y
    Molecular Weight:195.26
    CAS Registry Number:10361-92-9
  • 2-Butyrylaminopropinicacid

    2-Butyrylaminopropinicacid

    Product Name:2-Butyrylaminopropinicacid
    Molecular Formula:C7H13NO3
    Molecular Weight:159.18
    CAS Registry Number:59875-04-6
  • 2-Phenylacetophenone oxime

    2-Phenylacetophenone oxime

    Product Name:2-Phenylacetophenone oxime
    Molecular Formula:C14H13NO
    Molecular Weight:211.26
    CAS Registry Number:952-06-7
  • (S)-2,4-dichloro-a-(chloromethyl)-benzenemethanol

    (S)-2,4-dichloro-a-(chloromethyl)-benzenemethanol

    Product Name:(S)-2,4-dichloro-a-(chloromethyl)-benzenemethanol
    Molecular Formula:C9H9Cl3O3S
    Molecular Weight:303.59
    CAS Registry Number:229334-55-8
  • Calcitriol

    Calcitriol

    Product Name:Calcitriol
    Molecular Formula:C27H44O3
    Molecular Weight:416.64
    CAS Registry Number:32222-06-3
  • 4-Nitrobenzyl 2-diazoacetoacetate

    4-Nitrobenzyl 2-diazoacetoacetate

    Product Name:4-Nitrobenzyl 2-diazoacetoacetate
    Molecular Formula:C11H9N3O5
    Molecular Weight:263.21
    CAS Registry Number:82551-63-1
  • Related Blog
  • Reviews

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products...

  • How to find the best China API manufacturer?

    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.

  • TOP 8 Linezolid intermediate maker

    Sandoo Pharmaceuticals and Chemicals Co.,Ltd was established in 2009, with a creative and active team, located in Ningbo, China. We have been specialized in exporting and importing pharmaceutical intermediates and chemical products as well as API for more than 10 years, covering more than 10 countries.

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept